A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and effectiveness of 2 anti-HIV drug
combinations in HIV-infected patients. Both combinations will include nevirapine (NVP), 2
nucleoside reverse transcriptase inhibitors (NRTIs), and at least 1 protease inhibitor (PI).
One combination will include a new protease inhibitor, ABT-378, combined in a capsule with
ritonavir (RTV).